Last updated on November 2016

Topical Omega-3 Fatty Acids (REMOGEN OMEGA) in the Treatment of Dry Eye

Brief description of study

The primary objective of this study is to evaluate the efficacy of REMOGEN® OMEGA in reducing Dry Eye Syndrome (DES) symptoms.

Clinical Study Identifier: NCT02908282


Contact Investigators or Research Sites near you

Start Over

Please choose location

View all locations

Raphaela Geiger

Praxis Dr. Kaercher
Heidelberg, Germany
  Connect »

Raphaela Geiger

Praxis Prof. Dr. Anselm Kampik & Kollegen
Munich, Germany
  Connect »

Raphaela Geiger

Augenzentrum Olching
Olching, Germany
  Connect »